Mortality data 2004–2019: an audit of the Royal Adelaide Hospital Adult Burn Service

2020 ◽  
Author(s):  
Kristian Stefani ◽  
Marcus J. D. Wagstaff ◽  
Ivo Damkat ◽  
John E. Greenwood
Keyword(s):  
Adelaide Hospital ◽  
Mortality Data ◽  
Royal Adelaide Hospital

Combined chemotherapy and EUS-guided intra-tumoral 32-P implantation for locally advanced pancreatic ductal adenocarcinoma: a pilot study

Endoscopy ◽  
2021 ◽  
Author(s):  
Jeevinesh Naidu ◽  
Dylan Bartholomeusz ◽  
Joshua Zobel ◽  
Romina Safaeian ◽  
William Hsieh ◽  
...  
Keyword(s):  
Locally Advanced ◽  
Adelaide Hospital ◽  
Response To Treatment ◽  
Ductal Adenocarcinoma ◽  
Resection Margins ◽  
R0 Resection ◽  
Royal Adelaide Hospital ◽  
Combined Chemotherapy ◽  
Radioactive Phosphorus ◽  
18Fdg Pet

Aim: This study evaluated clinical outcomes of combined chemotherapy and Endoscopic Ultrasound (EUS) guided intra-tumoral radioactive phosphorus-32 (32P OncoSil) implantation in locally advanced pancreatic adenocarcinoma (LAPC). Methods: Consecutive patients with a new histological diagnosis of LAPC were recruited over 20 months. Baseline CT and 18FDG PET-CT were performed and repeated after 12 weeks to assess response to treatment. Following 2 cycles of conventional chemotherapy, patients underwent EUS-guided 32P OncoSil implantation followed by a further six cycles of chemotherapy. Results: Twelve patients with LAPC (8M:4F; median age 69 years, IQR 61.5-73.3) completed the treatment. Technical success was 100% and no procedural complications were reported. At 12 weeks, there was a median reduction of 8.2cm3 (95% CI 4.95-10.85; p=0.003) in tumour volume, with minimal or no 18FDG uptake in 9 (75%) patients. Tumour downstaging was achieved in 6 (50%) patients, leading to successful resection in 5 (42%) patients, of which 4 patients (80%) had clear (R0) resection margins. Conclusions: EUS guided 32P OncoSil implantation is feasible and well tolerated and was associated with a 42% rate of surgical resection in our cohort. However, further evaluation in a larger randomized multicenter trial is warranted. (32P funded by OncoSil Medical Ltd, equipment and staff funded by the Royal Adelaide Hospital, ClinicalTrials.gov number, NCT03003078).

Anaemia in elective orthopaedic surgery - Royal Adelaide Hospital, Australia

2016 ◽  
Vol 46 (1) ◽  
pp. 96-101 ◽  
Author(s):  
B. Kearney ◽  
J. To ◽  
K. Southam ◽  
D. Howie ◽  
B. To
Keyword(s):  
Orthopaedic Surgery ◽  
Adelaide Hospital ◽  
Royal Adelaide Hospital

INCREASING NUMBERS OF ADMISSIONS TO THE ADULT BURNS SERVICE AT THE ROYAL ADELAIDE HOSPITAL 2001?2004

2007 ◽  
Vol 77 (5) ◽  
pp. 358-363 ◽  
Author(s):  
John E. Greenwood ◽  
Richard Tee ◽  
Wendy L. Jackson
Keyword(s):  
Adelaide Hospital ◽  
Royal Adelaide Hospital

scholarly journals Reliability of Blood Sugar Reagent Strips

1974 ◽  
Vol 2 (3) ◽  
pp. 256-259 ◽  
Author(s):  
D. J. McCleave
Keyword(s):  
Blood Sugar ◽  
Severe Hypoglycaemia ◽  
Adelaide Hospital ◽  
Royal Adelaide Hospital ◽  
Lower Blood ◽  
Reagent Strips ◽  
The Stability

Two cases of severe hypoglycaemia following the use of insulin after blood sugar reagent strips indicated an erroneously high value, precipitated an investigation into the reliability of all reagent strips currently being used at the Royal Adelaide Hospital. It was found that when compared to Autoanalyzer values, such a method of blood sugar estimation is unacceptable for clinical useage. Reagent Strips taken from recently opened containers gave reasonably accurate results for lower blood sugar values. It is concluded that such inaccurate results are related to the stability of the reagent strips.

Sign in / Sign up

Export Citation Format

Share Document